CARBOTERO 150MG INJECTION contains Carboplatin, which belongs to the group of medicines called Anti-cancer agents. It is used to manage advanced ovarian cancer and small-cell lung cancer. It is generally used in combination with other anti-cancer medicines to achieve better results.
Advanced ovarian cancer is a cancer that originates in the ovary and spreads to other parts of the body and small cell lung cancer is cancer that occurs in the tissues of the lungs. It is caused mainly by smoking and is characterized by symptoms such as chest pain, coughing with blood, shortness of breath, tiredness, and weight loss.
Before receiving CARBOTERO 150MG INJECTION, inform your doctor if you have any liver or kidney problems. You must also inform your doctor if you have a fever or low blood counts before receiving CARBOTERO 150MG INJECTION. CARBOTERO 150MG INJECTION should not be used by pregnant or breastfeeding women.
Men receiving CARBOTERO 150MG INJECTION must not father a child during management with CARBOTERO 150MG INJECTION and up to six months after stopping the therapy. Both men and women receiving CARBOTERO 150MG INJECTION must use a suitable contraceptive method to avoid pregnancy while undergoing therapy with CARBOTERO 150MG INJECTION.
The use of CARBOTERO 150MG INJECTION may cause an abnormal decrease in total blood counts. It may also cause nausea, vomiting, mouth sores, hearing loss, loss of taste, tingling or numbness of body parts, increased serum creatinine levels, difficulty passing urine, increased bilirubin levels in the blood, and changes in vision.
To avoid this, your doctor will closely monitor your blood count, liver functions, kidney functions, nerve functions, and ear functions. However, consult your doctor if they trouble you.
No content available
